• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND ENDURANT II ILIAC STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND ENDURANT II ILIAC STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number ETLW1620C124E
Device Problems Leak/Splash (1354); Migration or Expulsion of Device (1395)
Patient Problem Abdominal Pain (1685)
Event Date 04/08/2024
Event Type  Injury  
Manufacturer Narrative
Continuation of d10: section d information references the main component of the system.Other relevant device(s) are: product id: e tbf3220c166e, serial/lot #: (b)(6), ubd: 12-mar-2021, udi#: (b)(4).Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event Description
An endurant ii stent graft (etbf3220c166e) and endurant limb (etlw1620c124e) were implanted during the endovascular treatment of a 7 8mm abdominal aortic aneurysm.It was reported approximately 5 years post the index procedure, the patient presented emergently experiencing abdominal pain.A ct scan revealed that both the limbs had pulled into the aneurysm sac causing bilateral type ib endoleaks in etbf3220c166e & e tlw1620c124e. intervention was performed and two additional endurant ii stent graft limbs (etlw1620c156) implanted on the right and (etlw1624c156e) placed on the left were successfully extended to the hypogastric resolving the type ib endoleak. per the physician the cause of the type ib endoleaks was anatomy related due to the patients short common iliac.No additional clinical sequalae were provided and the patient is fine.
 
Manufacturer Narrative
Film evaluation summary: the reported bilateral type ib endoleak and migration were confirmed on the films provided.Stent migration into the aneurysm sac was most likely a factor in the type ib endoleak, however, the cause of the migration could not be determined from the available films.Lack of pre-implant cts did not allow for assessment of the pre-implant anatomy and earlier pots-implant cts were not available for comparison of the stent graft configuration over time.It is possible that disease progression with aneurysm morphology changes and loss of seal over the duration of implantation of the devices associated with the reported short common iliac arteries may have been a factor in the occurrence of the observed events.Analysis of the returned films did not reveal any out of specification stent graft integrity issues.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDURANT II ILIAC STENT GRAFT
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
EI 
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
EI  
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key19094956
MDR Text Key339982892
Report Number9612164-2024-01762
Device Sequence Number1
Product Code MIH
UDI-Device Identifier00643169467552
UDI-Public00643169467552
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/15/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/27/2021
Device Model NumberETLW1620C124E
Device Catalogue NumberETLW1620C124E
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/08/2024
Initial Date FDA Received04/12/2024
Supplement Dates Manufacturer Received04/18/2024
Supplement Dates FDA Received05/15/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/28/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
"SEE H11...."
Patient Outcome(s) Required Intervention;
Patient Age66 YR
Patient SexMale
Patient Weight126 KG
-
-